1. Market Research
  2. > Pathology Industry

carcinoma Industry, May 2016 Market Reports from Top Publishers

You might be interested in: Diagnostics, Cancer Diagnostic, Pharmaceutical, Molecular Diagnostic, Therapy.


 
1-10 of 81 reports for Carcinoma

Purchase Reports From Reputable Market Research Publishers

Metastatic Hepatocellular Carcinoma (HCC) - Pipeline Review, H1 2016

Metastatic Hepatocellular Carcinoma (HCC) - Pipeline Review, H1 2016

  • $ 2 000
  • Company report
  • March 2016
  • by Global Markets Direct

Metastatic Hepatocellular Carcinoma (HCC) - Pipeline Review, H1 2016 Summary Global Markets Direct’s, ‘Metastatic Hepatocellular Carcinoma (HCC) - Pipeline Review, H1 2016’, provides an overview ...

Metastatic Renal Cell Carcinoma - Pipeline Review, H1 2016

Metastatic Renal Cell Carcinoma - Pipeline Review, H1 2016

  • $ 2 000
  • Company report
  • March 2016
  • by Global Markets Direct

Metastatic Renal Cell Carcinoma - Pipeline Review, H1 2016 Summary Global Markets Direct’s, ‘Metastatic Renal Cell Carcinoma - Pipeline Review, H1 2016’, provides an overview of the Metastatic Renal ...

Head and Neck Squamous Cell Carcinoma: KOL Insight

Head and Neck Squamous Cell Carcinoma: KOL Insight

  • $ 8 085
  • Industry report
  • March 2016
  • by Firstword Pharma

n/a

Neuroendocrine Carcinoma Global Clinical Trials Review, H1, 2016

Neuroendocrine Carcinoma Global Clinical Trials Review, H1, 2016

  • $ 2 500
  • Company report
  • February 2016
  • by Global Data

Neuroendocrine Carcinoma Global Clinical Trials Review, H1, 2016 Summary GlobalData's clinical trial report, “Neuroendocrine Carcinoma Global Clinical Trials Review, H1, 2016" provides an overview of ...

NPS+ Renal Cell Carcinoma (EU5)

NPS+ Renal Cell Carcinoma (EU5)

  • $ 2 668
  • Industry report
  • February 2016
  • by Firstword Pharma

Compare 8 major RCC brands. Learn which one scores 6 times higher than any other? FirstView’s NPS+ Renal Cell Carcinoma report compares brand loyalty for 8 major RCC treatments—information you can ...

NPS+ Renal Cell Carcinoma (US)

NPS+ Renal Cell Carcinoma (US)

  • $ 2 668
  • Industry report
  • February 2016
  • by Firstword Pharma

Two brands lead the RCC treatment market. How does your brand stack up? US oncologists may not be totally satisfied with available renal cell carcinoma (RCC) treatments, but two brands have earned high ...

Global Renal Cell Carcinoma Drugs Market 2020

Global Renal Cell Carcinoma Drugs Market 2020

  • $ 1 500
  • Industry report
  • February 2016
  • by RNCOS

Renal cell carcinoma, also called renal adenocarcinoma, is a disease in which malignant or cancerous cells are found in the lining of tubules in the kidney. There are many factors, like smoking, hypertension, ...

Head and Neck Squamous Cell Carcinoma -Pipeline Insights, 2016

Head and Neck Squamous Cell Carcinoma -Pipeline Insights, 2016

  • $ 2 250
  • Industry report
  • February 2016
  • by Delve Insight

Summary DelveInsight’s, “Head and Neck Squamous Cell Carcinoma -Pipeline Insights, 2016”, report provides comprehensive insights about pipeline drugs across this indication. A key objective of the ...

 Neuroendocrine Carcinoma-Pipeline Insights, 2016

Neuroendocrine Carcinoma-Pipeline Insights, 2016

  • $ 1 250
  • Industry report
  • January 2016
  • by Delve Insight

SUMMARY DelveInsight’s, “ Neuroendocrine Carcinoma-Pipeline Insights, 2016”, report provides in depth insights on the pipeline drugs and their development activities around the Neuroendocrine Carcinoma. ...

 Non-Small Cell Lung Carcinoma-Pipeline Insights, 2016

Non-Small Cell Lung Carcinoma-Pipeline Insights, 2016

  • $ 1 250
  • Industry report
  • January 2016
  • by Delve Insight

SUMMARY DelveInsight’s, “ Non-Small Cell Lung Carcinoma-Pipeline Insights, 2016”, report provides in depth insights on the pipeline drugs and their development activities around the Non-Small Cell ...

About 4 400 reports for Carcinoma

Download Unlimited Documents from Trusted Public Sources

Radiation Oncology Industry in the US

  • January 2016
    111 pages
  • Radiation Oncol...  

    Cancer  

  • United States  

View report >

Reportlinker.com © Copyright 2016. All rights reserved.

ReportLinker simplifies how Analysts and Decision Makers get industry data for their business.